Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries

Nutrition and Cancer

Volumn 51, Issue 2, 2005, Pages 207-217

  Han, Chunhua ^a   Ding, Haiming ^a   Casto, Bruce ^a,b   Stoner, Gary D ^a,b   D'Ambrosio, Steven M ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZO[A]PYRENE; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1; ELLAGIC ACID; FERULIC ACID; METHYL CHLORIDE; PLANT EXTRACT; RASPBERRY EXTRACT; SITOSTEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL TRANSFORMATION; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; EMBRYO; ESOPHAGUS CANCER; FLOW CYTOMETRY; FREEZE DRYING; HAMSTER; HUMAN; HUMAN CELL; MOUTH CANCER; NONHUMAN; PRECANCER; RASPBERRY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CELL LINE; CHEMOPREVENTION; COUMARIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; ETHANOL; FLOW CYTOMETRY; FRUIT; HUMANS; MODELS, BIOLOGICAL; MOUTH MUCOSA; MOUTH NEOPLASMS; PLANT EXTRACTS; PRECANCEROUS CONDITIONS; SITOSTEROLS; TUMOR CELLS, CULTURED;

CRICETINAE; RODENTIA; RUBUS GLAUCUS; RUBUS OCCIDENTALIS;

EID: 19544370181     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5102_11     Document Type: Article

References (51)

1. La V, Altieri A, and Tavani A: Vegetables, fruit, antioxidants and cancer: a review of Italian studies. Eur J Nutr 40, 261-267, 2001.
2. Vainio H and Bianchini F: Evaluation of cancer-preventive agents and strategies: a new program at the International Agency for Research on Cancer. Ann NY Acad Sci 952, 177-180, 2001.
3. Byers TE: Nutrition and cancer: ten lessons from the 20th century. Nutrition 16, 561-563, 2000.
4. Stoner GD, Weghorst CM, D'Ambrosio SM, Kresty LA, Harris GK, et al.: Prevention of cancer by berries and berry components. Pharmacol Ther, 2004. Forthcoming.
5. Casto BC, Kresty LA, Kraly CL, Pearl DK, Knobloch TJ, et al.: Chemoprevention of oral cancer by black raspberries. Anticancer Res 22, 4005-4015, 2002.
6. Wada L and Ou B: Antioxidant activity and phenolic content of Oregon caneberries. J Agric Food Chem 50, 3495-3500, 2002.
7. Wang SY and Jiao H: Scavenging capacity of berry crops on Superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem 48, 5677-5684, 2000.
8. Wang SY and Lin HS: Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem 48, 140-146, 2000.
9. Park EJ and Pezzuto JM: Botanicals in cancer chemoprevention. Cancer Metastasis Rev 21, 231-255, 2002.
10. Wang H, Cao G, and Prior RL: Total antioxidant capacity of fruits. J Agric Food Chem 44, 701-705, 1996.
11. Kähkönen MP, Hopia AI, Vuorela HJ, Pihlaja K, Kujala TS, et al.: Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 47, 3954-3962, 2002.
12. Katsube N, Iwashita K, Tsushida T, Yamaki K, and Kobori M: Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 51, 68-75, 2003.
13. Stoner GD, Kresty LA, Carlton PS, Siglin JC, and Morse MA: Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Toxicol Sci 52, 95-100, 1999.
14. Carlton PS, Kresty LA, Siglin JC, Morse MA, Lu J, et al.: Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 22, 441-446, 2001.
15. Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, et al.: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61, 6112-6119, 2001.
16. Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, et al.: Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer 40, 125-133, 2001.
17. Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, et al.: Inhibition of cellular transformation by berry extracts. Carcinogenesis 22, 351-356, 2001.
18. Huang C, Huang Y, Li J, Hu W, Aziz R, et al.: Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res 62, 6857-6863, 2002.
19. Walker DM, Boey G, and McDonald LA: The pathology of oral cancer. Pathology 35, 376-383, 2003.
20. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52, 195-215, 2002.
21. D'Ambrosio SM, D'Ambrosio REG, Milo GE, Casto BC, Kelloff GJ, et al.: Differential growth responses of normal, premalignant, and malignant human oral epithelial cells by chemopreventive agents. Anticancer Res 20, 2273-2280, 2000.
22. Lee H, Li D, Prior T, Casto BC, Weghorst CM, et al.: Ineffectiveness of the presence of h-ras/p53 combination mutations in squamous cell carcinoma cells to induce the conversion of a nontumorigenic to a tumorigenic tumor type. Cell Biol Toxicol 13, 419-434, 1997.
23. Milo GE, Shuler C, Kurian P, French BT, Mannix DG, et al.: Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC. Proc Natl Acad Sci USA 87, 1268-1272, 1990.
24. Greenberg O, Terespolosky Y, Kahane I, and Bar R: Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas. Appl Environ Microbiol 59, 547-551, 1993.
25. Ding H, Han C, Gibson-D'Ambrosio R, Steele VE, and D'Ambrosio SM: Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1. Int J Cancer 107, 830-836, 2003.
26. Gerber M, Boutron R, Hercberg S, Riboli E, Scalbert A, et al.: [Food and cancer: state of the art about the protective effect of fruits and vegetables]. Bull Cancer 89, 293-312, 2002.
27. Dong Y, Sui L, Tai Y, Sugimoto K, and Tokuda M: The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas. Anticancer Res 21, 103-108, 2001.
28. Quon H, Liu FF, and Cummings BJ: Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23, 147-159, 2001.
29. Liu SC and Klein-Szanto AJ: Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 36, 145-151, 2000.
30. Hassan K, Ang K, El-Naggar A, Story M, Lee J, et al.: Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 62, 6414-6417, 2002.
31. Bukholm I, Bukholm G, and Nesland J: Coexpression of cyclin A and beta-catenin and survival in breast cancer patients. Int J Cancer 94, 148-149, 2001.
32. Opitz O, Harada H, Suliman Y, Rhoades B, Sharpless N, et al.: A mouse model of human oral-esophageal cancer. J Clin Invest 110, 761-769, 2002.
33. Cazzalini O, Perucca P, Valsecchi F, Stivala LA, Bianchi L, et al.: Intracellular localization of the cyclin-dependent kinase inhibitor p21 (CDKN1A)-GFP fusion protein during cell cycle arrest. Histochem Cell Biol 121, 377-381, 2004.
34. Dupont J, Karas M, and LeRoith D: The Cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor induced cell proliferation in MCF-7 human breast cancer cells. J Biol Chem 278, 37256-37264, 2003.
35. Liu WK, Sze SC, Ho JC, Liu BP, and Yu MC: Wheat germ lectin induces G2/M arrest in mouse L929 fibroblasts. J Cell Biochem 91, 1159-1173, 2004.
36. Kim OH, Lim JH, Woo KJ, Kim YH, Jin IN, et al.: Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors. Int J Oncol 24, 935-941, 2004.
37. Kobayashi T, Nakata T, and Kuzumaki T: Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176, 17-23, 2002.
38. Hudson EA, Dinh PA, Kokubun T, Simmonds MSJ, and Gescher A: Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 9, 1163-1170, 2000.
39. Bourne LC and Rice-Evans C: Bioavailability of ferulic acid. Biochem Biophys Res Commun 253, 222-227, 1998.
40. Zhang K and Zuo Y: GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juice. J Agricult Food Chem 52, 222-227, 2004.
41. Awad AB, Roy R, and Fink CS: Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncol Rep 10, 497-500, 2003.
42. Park KY, Cho EJ, Rhee SH, Jung KO, Yi SJ, et al.: Kimchi and an active component, beta-sitosterol, reduce oncogenic H-Ras(v12)-induced DNA synthesis. J Med Food 6, 151-156, 2003.
43. Awad AB, Williams H, and Fink CS: Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells. Nutr Cancer 40, 157-164, 2001.
44. Awad AB, Downie AC, and Fink CS: Inhibition of growth and stimulation of apoptosis by beta-sitosterol treatment of MDA-MB-231 human breast cancer cells in culture. Int J Mol Med 5, 541-545, 2000.
45. Awad AB, Gan Y, and Fink CS: Effect of beta-sitosterol, a plant sterol, on growth, protein phosphatase 2A, and phospholipase D in LNCaP cells. Nutr Cancer 36, 74-78, 2000.
46. Awad AB, von Holtz RL, Cone JP, Fink CS, and Chen YC: Beta-sitosterol inhibits growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle. Anticancer Res 18, 471-473, 1998.
47. von Holtz RL, Fink CS, and Awad AB: Beta-sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer 32, 8-12, 1998.
48. Awad AB, Chen YC, Fink CS, and Hennessey T: Beta-sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids. Anticancer Res 16, 2797-2804, 1996.
49. Awad AB, Williams H, and Fink CS: Effect of phytosterols on cholesterol metabolism and MAP kinase in MDA-MB-231 human breast cancer cells. J Nutr Biochem 14, 111-119, 2003.
50. Awad AB and Fink CS: Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 130, 2127-2130, 2000.
51. Ling WH and Jones PJH: Minireview dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 57, 195-206, 1995.